For Funded Healthtech CEOs

Before you scale go-to-market, test the market thesis.

You raised to grow. Rehinged tests the markets, buyers and GTM assumptions before you lock hires, territories and budget around them — then turns the evidence into work your commercial team can run.

FREE MARKET DRAFT · NO CARD · NO MANDATORY CALL · NOBODY CALLS UNLESS YOU ASK
The GTM decisionThree candidate markets
ILLUSTRATIVE GTM HYPOTHESES
SKILLED NURSINGhypothesis 01
HOME HEALTHhypothesis 02
SPECIALTY PHYSICIANShypothesis 03
Provider & facility evidenceSOURCE-DATED
Quality · survey · staffing evidenceSOURCE-DATED
Medicare prescribing & procedure evidenceRETROSPECTIVE
Current enrichmentCURRENT
Your first-party contextYOURS
SKILLED NURSINGFacility-level demand scoring
HOME HEALTHEpisode & referral scoring
SPECIALTY PHYSICIANSPrescriber-level fit scoring
There is no universal best target. Fit changes with what you sell.
ILLUSTRATIVE RANKING · NO SCORES WITHOUT EVIDENCE
1Skilled NursingFIRST TEST
2Home HealthSECONDARY
3Specialty PhysiciansVALIDATE BUYER FIRST
GTM Decision BriefILLUSTRATIVE
LEAD MARKETSkilled Nursing
PRIMARY BUYERDirector of Nursing / Administrator
FIRST TESTValidate demand with the highest-fit account cohort
NEXT QUESTIONDoes the buyer / product hypothesis survive real account evidence?
Illustrative decision framework · real Market Drafts carry the supporting evidence
After the round

A funding round buys time. A bad GTM thesis burns it.

01
Hire around assumptions

Territories, quotas and the first sales hires harden a market thesis before the evidence has really tested it.

02
Buy data and inherit more work

A database can expand what the team knows. It does not decide which market deserves the next dollar or turn the answer into finished commercial work.

03
Spend the quarter learning

The company does the analysis while the board expects execution. By the time the target list is ready, part of the market has already moved.

Test the thesis before you hire around it.
The decision

Bring us the GTM assumptions your leadership team is debating.

“Should SNFs or home health be market one?”

“Is Clinical really the buyer — or just the champion?”

“Do we hire into the Southeast first?”

“Which use case deserves the first ICP?”

“Is weak pipeline a targeting problem, a positioning problem, or a market problem?”

The job is not to confirm your GTM thesis. It is to determine whether the market supports it.

The work

The work you need before the hiring plan hardens.

The Full Build gives you the scored market foundation. From that foundation, Rehinged can produce the finished GTM work your team needs next.

THE FULL BUILD · THE FOUNDATION
01Market · TAM / SAM / SOM
02ICP architecture
03Scored target market
04Buyer logic
05Reasons to call
06Buying signals
07Draft outreach
08Rehinged Intelligence workspace
AFTER THE FULL BUILD · FINISHED WORK
01Competitive battlecards
02Talk tracks & messaging
03Comprehensive GTM plan
04Territory prep
05Campaign & enablement work
SCORED TARGET WORKBOOK
TALK TRACKS & CAMPAIGNS
GTM Decision BriefILLUSTRATIVE
THE DECISIONWhich market should receive the next 90 days?
WHAT THE EVIDENCE SUPPORTSA lead market, named — with the evidence logic behind the call
BUYERThe buyer the evidence supports — champion and signer, separately
FIRST 100 ACCOUNTSThe highest-fit cohort from the scored market, ranked, with the reason to call
WHAT TO TEST NEXTThe assumption that decides the next quarter — and how to test it
CONFIDENCEOBSERVED · CALCULATED · ENRICHED · INFERRED · UNKNOWN

Not recommendations left in a deck. Finished commercial work inside a persistent Rehinged Intelligence workspace.

Data → decision → work

Another healthcare database is useful only if someone turns it into a GTM decision.

DATA / SOFTWARE PLATFORM
  • Starts with a dataset
  • Gives the team access
  • Team analyzes
  • Team constructs ICPs
  • Team decides what matters
  • Team builds the commercial work
REHINGED
  • Starts with your commercial question
  • Tests the market thesis
  • Builds the scoring around what you sell
  • Scores the real market
  • Produces the commercial answer
  • Delivers finished work
Data is an input. The GTM decision is the product.
Start small

The first question costs nothing to ask.

Market Draft
FREE
First evidence-backed read on your company, markets and GTM hypothesis.
Full Build
$4,000 PER MARKET · ONE-TIME · REFRESH $500 WHEN NEEDED
Complete healthcare market intelligence build.
Revenue Engineer
TYPICALLY $5,000–$12,000 / MONTH
For companies that want Rehinged operating alongside the commercial team after the foundation exists.

Once your Full Build is complete, we can scope additional commercial work against the market we’ve built together.

If the Market Draft does not earn the next step, stop there.

Your Market Draft

Tell us the GTM decision you need to make.

Finish the sentence. We’ll test it against the market. The Market Draft is free.

MARKET DRAFT · WORK ORDERSEVEN BLANKS · TWO MINUTES

We sell into .
We think the buyer is , and the GTM decision we need to make is .

We’re () — reach me at .

Questions first? Read the FAQ →

Market Draft queued.

We’ll test the markets, buyer assumptions and GTM decision you gave us against the available healthcare evidence. Your Market Draft will show what the market supports, where the evidence is weak, and what we recommend testing next.

Your Rehinged Intelligence workspace will open with your Market Draft and the complete Meridian Reference Build so you can judge the finished work.

Most Market Drafts are live within 1–2 business days. We’ll tell you if yours takes longer.

MARKET DRAFT · QUEUED FOR EVIDENCE TEST
WE FOLLOW UP BY EMAIL ONLY · NOBODY CALLS UNLESS YOU ASK

The job is not to confirm your GTM thesis — it is to determine whether the market supports it. If the market does not support the thesis, we will say so. What you tell us about your company stays yours — governed by our privacy terms, never sold, and never used to build another client’s market.

FREE · NO CARD · NO MANDATORY CALL · NOBODY CALLS YOU UNLESS YOU ASK